O	0	1	A	A	DT	B-NP
O	2	7	novel	novel	JJ	I-NP
O	8	16	putative	putative	JJ	I-NP
O	17	25	tyrosine	tyrosine	NN	I-NP
O	26	32	kinase	kinase	NN	I-NP
O	33	41	receptor	receptor	NN	I-NP
O	42	46	with	with	IN	B-PP
O	47	56	oncogenic	oncogenic	JJ	B-NP
O	57	66	potential	potential	NN	I-NP
O	66	67	.	.	.	O

O	69	71	We	We	PRP	B-NP
O	72	76	have	have	VBP	B-VP
O	77	85	detected	detect	VBN	I-VP
O	86	98	transforming	transform	VBG	I-VP
O	99	107	activity	activity	NN	B-NP
O	108	110	by	by	IN	B-PP
O	111	112	a	a	DT	B-NP
O	113	127	tumorigenicity	tumorigenicity	NN	I-NP
O	128	133	assay	assay	NN	I-NP
O	134	139	using	use	VBG	B-VP
B-Cell	140	146	NIH3T3	NIH3T3	NN	B-NP
I-Cell	147	152	cells	cell	NNS	I-NP
O	153	164	transfected	transfecte	VBN	B-VP
O	165	169	with	with	IN	B-PP
O	170	173	DNA	DNA	NN	B-NP
O	174	178	from	from	IN	B-PP
O	179	180	a	a	DT	B-NP
O	181	188	chronic	chronic	JJ	I-NP
O	189	207	myeloproliferative	myeloproliferative	JJ	I-NP
O	208	216	disorder	disorder	NN	I-NP
O	217	224	patient	patient	NN	I-NP
O	224	225	.	.	.	O

O	226	230	Here	Here	RB	B-ADVP
O	230	231	,	,	,	O
O	232	234	we	we	PRP	B-NP
O	235	241	report	report	VBP	B-VP
O	242	245	the	the	DT	B-NP
O	246	250	cDNA	cDNA	NN	I-NP
O	251	258	cloning	cloning	NN	I-NP
O	259	261	of	of	IN	B-PP
O	262	265	the	the	DT	B-NP
O	266	279	corresponding	correspond	VBG	I-NP
O	280	288	oncogene	oncogene	NN	I-NP
O	288	289	,	,	,	O
O	290	300	designated	designate	VBN	B-VP
O	301	304	UFO	UFO	NNP	B-NP
O	304	305	,	,	,	O
O	306	308	in	in	IN	B-PP
O	309	317	allusion	allusion	NN	B-NP
O	318	320	to	to	TO	B-PP
O	321	324	the	the	DT	B-NP
O	325	327	as	as	RB	I-NP
O	328	331	yet	yet	RB	I-NP
O	332	344	unidentified	unidentified	JJ	I-NP
O	345	353	function	function	NN	I-NP
O	354	356	of	of	IN	B-PP
O	357	360	its	its	PRP$	B-NP
O	361	368	protein	protein	NN	I-NP
O	368	369	.	.	.	O

O	370	380	Nucleotide	Nucleotide	NN	B-NP
O	381	389	sequence	sequence	NN	I-NP
O	390	398	analysis	analysis	NN	I-NP
O	399	401	of	of	IN	B-PP
O	402	403	a	a	DT	B-NP
O	404	410	3116bp	3116bp	NN	I-NP
O	411	415	cDNA	cDNA	NN	I-NP
O	416	421	clone	clone	NN	I-NP
O	422	430	revealed	reveal	VBD	B-VP
O	431	432	a	a	DT	B-NP
O	433	437	2682	2682	CD	I-NP
O	437	438	-	-	HYPH	I-NP
O	438	440	bp	bp	NN	I-NP
O	440	441	-	-	HYPH	B-NP
O	441	445	long	long	JJ	I-NP
O	446	450	open	open	JJ	I-NP
O	451	458	reading	reading	NN	I-NP
O	459	464	frame	frame	NN	I-NP
O	465	472	capable	capable	JJ	B-ADJP
O	473	475	of	of	IN	B-PP
O	476	485	directing	direct	VBG	B-VP
O	486	489	the	the	DT	B-NP
O	490	499	synthesis	synthesis	NN	I-NP
O	500	502	of	of	IN	B-PP
O	503	504	a	a	DT	B-NP
O	505	508	894	894	CD	I-NP
O	509	514	amino	amino	NN	I-NP
O	515	519	acid	acid	NN	I-NP
O	520	531	polypeptide	polypeptide	NN	I-NP
O	531	532	.	.	.	O

O	533	536	The	The	DT	B-NP
O	537	546	predicted	predict	VBN	I-NP
O	547	550	UFO	UFO	NN	I-NP
O	551	558	protein	protein	NN	I-NP
O	559	567	exhibits	exhibit	VBZ	B-VP
O	568	582	characteristic	characteristic	JJ	B-NP
O	583	591	features	feature	NNS	I-NP
O	592	594	of	of	IN	B-PP
O	595	596	a	a	DT	B-NP
B-Cellular_component	597	610	transmembrane	transmembrane	NN	I-NP
O	611	619	receptor	receptor	NN	I-NP
O	620	624	with	with	IN	B-PP
O	625	635	associated	associate	VBN	B-NP
O	636	644	tyrosine	tyrosine	NN	I-NP
O	645	651	kinase	kinase	NN	I-NP
O	652	660	activity	activity	NN	I-NP
O	660	661	.	.	.	O

O	662	665	The	The	DT	B-NP
O	666	669	UFO	UFO	NNP	I-NP
O	670	675	proto	proto	AFX	I-NP
O	675	676	-	-	HYPH	I-NP
O	676	684	oncogene	oncogene	NN	I-NP
O	685	689	maps	map	NNS	I-NP
O	690	692	to	to	TO	B-PP
O	693	698	human	human	JJ	B-NP
B-Cellular_component	699	709	chromosome	chromosome	NN	I-NP
I-Cellular_component	710	715	19q13	19q13	CD	I-NP
I-Cellular_component	715	716	.	.	.	I-NP
I-Cellular_component	716	717	1	1	CD	I-NP
O	718	721	and	and	CC	O
O	722	724	is	be	VBZ	B-VP
O	725	736	transcribed	transcribe	VBN	I-VP
O	737	741	into	into	IN	B-PP
O	742	745	two	two	CD	B-NP
O	746	747	5	5	CD	I-NP
O	747	748	.	.	.	O
O	748	749	0	0	CD	B-NP
O	750	752	kb	kb	NN	I-NP
O	753	756	and	and	CC	O
O	757	758	3	3	CD	B-NP
O	758	759	.	.	.	O
O	759	760	2	2	CD	B-NP
O	761	763	kb	kb	NN	I-NP
O	764	769	mRNAs	mRNA	NNS	I-NP
O	770	772	in	in	IN	B-PP
O	773	778	human	human	JJ	B-NP
B-Multi-tissue_structure	779	783	bone	bone	NN	I-NP
I-Multi-tissue_structure	784	790	marrow	marrow	NN	I-NP
O	791	794	and	and	CC	O
O	795	800	human	human	JJ	B-NP
B-Cell	801	806	tumor	tumor	NN	I-NP
I-Cell	807	811	cell	cell	NN	I-NP
I-Cell	812	817	lines	line	NNS	I-NP
O	817	818	.	.	.	O

O	819	822	The	The	DT	B-NP
O	823	826	UFO	UFO	NNP	I-NP
O	827	832	locus	locus	NN	I-NP
O	833	835	is	be	VBZ	B-VP
O	836	850	evolutionarily	evolutionarily	RB	I-VP
O	851	860	conserved	conserve	VBN	I-VP
O	861	868	between	between	IN	B-PP
O	869	879	vertebrate	vertebrate	NN	B-NP
O	880	887	species	specie	NNS	I-NP
O	887	888	.	.	.	O

O	889	890	A	A	DT	B-NP
O	891	892	4	4	CD	I-NP
O	892	893	.	.	.	I-NP
O	893	894	0	0	CD	I-NP
O	895	897	kb	kb	NN	I-NP
O	898	902	mRNA	mRNA	NN	I-NP
O	903	905	of	of	IN	B-PP
O	906	909	the	the	DT	B-NP
O	910	916	murine	murine	JJ	I-NP
O	917	920	UFO	UFO	NNP	I-NP
O	921	928	homolog	homolog	NN	I-NP
O	929	931	is	be	VBZ	B-VP
O	932	941	expressed	express	VBN	I-VP
O	942	944	in	in	IN	B-PP
O	945	946	a	a	DT	B-NP
O	947	954	variety	variety	NN	I-NP
O	955	957	of	of	IN	B-PP
O	958	967	different	different	JJ	B-NP
O	968	973	mouse	mouse	NN	I-NP
B-Tissue	974	981	tissues	tissue	NNS	I-NP
O	981	982	.	.	.	O

O	983	985	We	We	PRP	B-NP
O	986	990	thus	thus	RB	B-ADVP
O	991	995	have	have	VBP	B-VP
O	996	1006	identified	identify	VBN	I-VP
O	1007	1008	a	a	DT	B-NP
O	1009	1014	novel	novel	JJ	I-NP
O	1015	1022	element	element	NN	I-NP
O	1023	1025	of	of	IN	B-PP
O	1026	1029	the	the	DT	B-NP
O	1030	1037	complex	complex	JJ	I-NP
O	1038	1047	signaling	signaling	NN	I-NP
O	1048	1055	network	network	NN	I-NP
O	1056	1064	involved	involve	VBN	B-VP
O	1065	1067	in	in	IN	B-PP
O	1068	1071	the	the	DT	B-NP
O	1072	1079	control	control	NN	I-NP
O	1080	1082	of	of	IN	B-PP
B-Cell	1083	1087	cell	cell	NN	B-NP
O	1088	1101	proliferation	proliferation	NN	I-NP
O	1102	1105	and	and	CC	O
O	1106	1121	differentiation	differentiation	NN	B-NP
O	1121	1122	.	.	.	O

